INF Healthcare Revenue and Competitors

Bronx, NY USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • INF Healthcare's estimated annual revenue is currently $9.5M per year.(i)
  • INF Healthcare's estimated revenue per employee is $216,000

Employee Data

  • INF Healthcare has 44 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M323%N/AN/A
#2
$13.4M5510%N/AN/A
#3
$25.4M9411%N/AN/A
#4
$78.4M26416%N/AN/A
#5
$9.3M4310%N/AN/A
#6
$51.1M17224%N/AN/A
#7
$65M2190%N/AN/A
#8
$44.8M1519%N/AN/A
#9
$6.7M31-11%N/AN/A
#10
$9.5M447%N/AN/A
Add Company

What Is INF Healthcare?

INF Healthcare is a leading, independently owned revenue cycle management organization that exclusively serves HME/DME Providers, hospitals, health systems and physician practices using an integrated, multi-disciplinary, tailored approach. We provide measurable value to our clients with deep functional expertise in RCM consulting, credentialing, medical coding, billing and collections, and denial management services. We help organizations create the better patient experience and attain their business objectives.

keywords:N/A

N/A

Total Funding

44

Number of Employees

$9.5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

INF Healthcare News

2022-04-20 - InfuSystem stock surges postmarket on master service deal ...

Service will be conducted on-site at the acute care facility or off-site at one of INFU's service centers. The global healthcare firm's...

2022-04-19 - Samsung Medical Center in South Korea first to achieve Stage ...

The eight-stage INFRAM measures the maturity of a healthcare facility's IT infrastructure across five areas: mobility, security,...

2022-04-19 - Rapid Infuser Market 2022 Trends–Advancements in ...

Europe is the second largest region to grow in the rapid infusers market due to advancement in healthcare infrastructure.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M447%N/A
#2
$1.7M442%N/A
#3
$9.7M457%N/A
#4
$8.2M4522%N/A
#5
$11.6M452%N/A